700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02095

Synthetic patientMETA-24 · Day 176 · 25–34 · M · baseline S08Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
10%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S08
  2. Day 103 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 103.

Primary contributors, last 14 days
  • Toxicity-24
  • Inflammatory activity-14
  • Nutritional resilience+10
  • GI instability-6

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    78 min
    stable · +1.1 vs previous 14 d
    Sleep duration
    Wearable
    6.1 h
    stable · +0.1 vs previous 14 d
    Energy level
    Daily log
    6.4/10
    improving · +0.7 vs previous 14 d
    Steps
    Wearable
    8,940
    stable · -164 vs previous 14 d
    GI burden
    Companion
    16.3/100
    improving · -3.7 vs previous 14 d
    Adherence
    Companion
    91.2 %
    stable · +0.2 vs previous 14 d
    Sleep quality
    Wearable
    42.3/100
    improving · +3.6 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    124 mg/dL
    stable · +0.1 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 80 from the failing basin, 12 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein (supports)
      perturbation · steering +7.1
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -3.6 next day
    Main detractors to watch
    • Enterobacteriaceae elevated
      hidden · steering -7.4
    • IL6 high-expression variant
      hidden · steering -7.3
    • Ultra-processed food
      perturbation · steering -4.8
    • Poor-sleep week
      perturbation · steering -3
    • Ultra-processed food
      detractor · GI +2.8 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -3.6supporter · 95%
    • Ultra-processed food
      +2.8detractor · 95%
    • Alcohol
      +1.5no signal · 53%
    • Insoluble fibre
      +1.4no signal · 35%
    • Simple carbohydrates
      +1.2no signal · 33%
    • Caffeine
      +0.7no signal · 22%
    • Histamine load
      +0.6no signal · 19%
    • Dietary fat load
      -0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity ↓40
      • MicrobiomeAkkermansia low → thinner mucus layer
      • WearableSleep 6.1 h, below personal baseline
    • Inflammatory signalling ↓25
      • DNAIL6 -174 variant raises baseline inflammatory tone
    • Autonomic recovery ↑20
      • WearableShort sleep window
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 3.5 · butyrate capacity 69/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    41 ms
    Sleep
    6.0 h
    Steps
    8,291
    Resting HR
    67 bpm
    Daily log: GI score 16, nutritional resilience 68, adherence 91.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0251849%S17DT-01improved68
    P-0246247%S12DT-01improved65
    P-0269847%S06ME-01improved71
    P-0262044%S01HY-01improved64
    P-0253843%S02GI-04improved59
    P-0235442%S01CR-01improved78
    P-0264541%S02HY-01improved56
    P-0203340%S06GI-04improved51
    P-0223540%S14DT-01improved50
    P-0212639%S16DT-01improved59
    P-0214739%S13GI-04improved58
    P-0221839%S01DT-01improved61